EZH2 and experimental autoimmune encephalomyelitis: However, in experimental model of autoimmune diseases including dextran sulfate sodium (DSS)-induced colitis and experimental autoimmune encephalomyelitis (EAE), EZH2 in the macrophage induced autoimmune disease progression, and inhibition of EZH2 reduced pro-inflammatory responses (13).